Madrid, Spain—A new study has linked a branded saffron extract, affron, with an improvement in psychological symptoms of menopause. A press release from Pharmactive, makers of affron, explains that perimenopause includes symptoms ranging from hot flashes to changes in cognitive function, performance, and mood. This study, published in the Journal...
Madrid, Spain—Branded saffron extract Affron has been awarded a U.S. patent for its positive role in low mood support, according to a press release from Pharmactive Biotech Products. The patent protects the proprietary composition and dosages of affron. “This new accreditation marks a momentous milestone for affron as it positions...
Anyone in the dietary supplement industry can attest to the impact of the COVID-19 pandemic on the dramatic sales increase of dietary supplements. Sales were $48 billion in 2019, then grew to $52 billion in 2020, and are projected to reach $58 billion this year (1). Among these increased sales,...
Pharmactive Biotech Products S.L. has announced its AffronEYE, a fast-absorbing saffron ingredient antioxidant that can potentially address the negative impacts of blue-light exposure and provide overall support to eye health, the company claims. AffronEYE is derived of all natural extraction of 100% Spanish saffron and is standardized to 3% crocins.
Austin, TX—Pharmactive Biotech Products has adopted saffron through the American Botanical Council’s (ABC) Adopt-an-Herb botanical research and education program, according to a press release. Saffron (Crocus sativus) is an autumn-flowering perennial, and one of the most expensive spices in the world: The part of the plant used medicinally and as...
Saffron has shown promise in the treatment of depression, but as an adjunct therapy, its efficacy may be limited, according to a new study in the Journal of Psychopharmacology. 160 adults with persistent depression and taking a pharmaceutical antidepressant enrolled in the randomized, double-blind, placebo-controlled study; 139 gave usable data.
